๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevalence of cerebral microhemorrhages at screening in an Alzheimer's disease clinical trial population

โœ Scribed by Kasia Lobello; David Li; Kevin Booth; Lisa Hua; Michael Cook; Achim Gass; Ronald Black


Book ID
118467524
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
53 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Analysis of longitudinal data in an Alzh
โœ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 2 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a